The 9 most recent market catalysts affecting $THRM, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 15, 2026
Corporate Catalyst
Bullish
Impact 65
JP Morgan Upgrades Gentherm to Overweight, Maintains Price Target to $48
JP Morgan analyst Rajat Gupta upgraded Gentherm (THRM) from Neutral to Overweight, maintaining a $48 price target. This upgrade indicates a more bullish outlook from a prominent in…
Jul 24, 2026
Corporate Catalyst
Bullish
Impact 65
Stifel Maintains Buy on Gentherm, Raises Price Target to $59
Stifel analyst Nathan Jones maintained a 'Buy' rating on Gentherm (THRM) and significantly raised the price target from $44 to $59. This action indicates a strong positive outlook …
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 65
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
The filing highlights significant intraday price fluctuations for a selection of consumer discretionary stocks. Gentherm, Mobileye Global, and Tesla explicitly linked their movemen…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 92
Gentherm shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance with its midpoint above estimates. Also, the company approved a new $400 million stock buyback program.
This headline represents a major positive catalyst for Gentherm (THRM). The combination of better-than-expected Q2 earnings, a significant increase in long-term sales guidance (FY2…
Jul 23, 2026
Corporate Catalyst
Neutral
Impact 65
Gentherm Board Approves New $400M Stock Buyback Program
Gentherm's board has authorized a new $400 million stock repurchase program, which will supersede the current program set to expire in July 2026. This new authorization, effective …
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 75
Gentherm Raises FY2026 Sales Guidance from $1.500B-$1.600B to $1.550B-$1.650B vs $1.560B Est
Gentherm (THRM) has raised its FY2026 sales outlook from $1.500 billion-$1.600 billion to $1.550 billion-$1.650 billion, exceeding the prior $1.560 billion estimate. This upward re…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 75
Gentherm Q2 Adj. EPS $0.75 Beats $0.56 Estimate, Sales $416.166M Beat $382.823M Estimate
Gentherm's substantial beat on both earnings per share and revenue estimates signals strong operational performance and potentially healthy demand within its core markets, primaril…
Jul 22, 2026
Corporate Catalyst
Neutral
Impact 75
Gentherm Acquires Innovative Medical Equipment; Financial Terms Undisclosed
Gentherm (THRM) has acquired Innovative Medical Equipment (IME), a company specializing in the ThermaZone® thermal therapy device. This acquisition is a strategic move to bolster G…
Jul 20, 2026
Corporate Catalyst
Bullish
Impact 55
Stifel Maintains Buy on Gentherm, Raises Price Target to $44
Stifel analyst Nathan Jones maintained a 'Buy' rating on Gentherm and raised the price target from $38 to $44. This action signals continued analyst confidence in Gentherm's future…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.